Malignant melanoma of the conjunctiva: A case report with examination of KIT and PDGFRA

Rare Tumors

Volumn 4, Issue 1, 2012, Pages 21-23

  Terada, Tadashi ^a  

^a SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

Author keywords

Conjunctiva; KIT; Malignant melanoma; PDGFRA

Indexed keywords

CHLOROFORM; CYTOKERATIN; CYTOKERATIN AE1; CYTOKERATIN AE3; CYTOKERATIN CAM5.2; GENOMIC DNA; KI 67 ANTIGEN; MELANIN; MONOCLONAL ANTIBODY HMB 45; PHENOL; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN P53; PROTEIN S 100; PROTEIN TYROSINE KINASE; PROTEINASE K; RECEPTOR TYROSINE KINASE KIT; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; CONJUNCTIVA TUMOR; CONJUNCTIVAL MELANOMA; DNA EXTRACTION; EPITHELIOID CELL; EXON; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; KIT GENE; MELANOMA; METASTASIS; PDGFRA GENE; PHYSICAL EXAMINATION; PROTEIN EXPRESSION; TUMOR BIOPSY; TUMOR CELL; TUMOR VOLUME;

EID: 84859647034     PISSN: 20363605     EISSN: 20363613     Source Type: Journal    
DOI: 10.4081/rt.2012.e8     Document Type: Article

References (25)

1. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006;24: 4340-6.
2. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005;353: 2135-47.
3. Hirota S, Isozaki K. Pathology of gastrointestinal stromal tumor. Pathol Int 2006;56: 1-9.
4. Alexeev V, Yoon K. Distinctive role of c-Kit receptor tyrosine kinase signaling in mammalian melanocytes. J Invest Dermatol 2006;126:1102-10.
5. Curtin JA, Pinkel D, Bastian BC. Absence of PDGFRA mutations in primary melanoma. J Invest Dermatol 2008;128: 488-9.
6. Ashida A, Takata M, Murata H, et al. Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas. Int J Cancer 2009;124: 862-8.
7. Terada T. Low incidence of KIT gene mutations and no PDGFRA gene mutations in primary cutaneous melanoma: an immunohistochemical and molecular genetic study of Japanese cases. Int J Clin Oncol 2010;15;453-6.
8. Terada T. Amelanotic malignant melanoma of the esophagus: report of two cases with immunohistocheimcal and molecular genetic study of KIT and PDGFRA. World J Gastroenterol 2009;15:2679-83.
9. Sober AJ, Lew RA, Koh HK, Barnhill RL. Epidemiology of cutaneous melanoma: an update. Dermatol Clin 1991;9:617-29.
10. Folberg R, McLean IW, Zimmerman LE. Malignant melanoma of the conjunctiva. Hum Pathol 1985;16:136-43.
11. De Potter P, Shields CL, Shields JA, Menduke H. Clinical predictive factors forsthe development of recurrence and metastasis of conjunctival melanoma: a review of 68 cases. Br J Ophthalmol 1993;77:624-30.
12. Terada T, Kawaguchi M, Furukawa K, et al. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int 2002;52:740-6.
13. Terada T, Taniguchi M. Intraductal oncocytic papillary neoplasm of the liver. Pathol Int 2004;54:116-23.
14. Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med 2005;206:271-5.
15. Terada T. Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Oncol 2009;28:29-34.
16. Terada T. Mediastinal seminoma with multiple KIT gene mutations. Pathology 2009;41:695-7.
17. Terada T. Mutations and protein expression of KIT and PDGFRA genes in ipsilateral testicular seminomas: an immunohistochemical and molecular genetic study. Appl Immunohistochem Mol Morphol 2011;19:450-3.
18. Terada T. Primary extragastrointestinal stromal tumors of the transverse mesocolon without c-kit mutations but with PDGFRA mutations. Med Oncol 2009;26: 233-7.
19. Terada T. Primary multiple extragastrointestinal stromal tumors of the omentum with different mutations of c-kit gene. World J Gastroenterol 2008;14:7256-9.
20. Sihto H, Sarlomo-Rikara M, Tynnienen O, et al. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J Clin Oncol 2005;23:49-57.
21. Willmore-Payne C, Holden JA, Tripps S, Layfield LJ. Human malignant melanoma: detection of BRAF-and c-kit-activating mutations by high-resolution amplicon melting analysis. Hum Pathol 2005;36:486-93.
22. Beadling C, Jacobson-Dunlop E, Hodi FS, et al. KIT gene mutation and copy number in melanoma subtypes. Clin Cancer Res 2008;14:6821-8.
23. Handlias D, Salemi R, Murray W, et al. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure. Pigment Cell Melanoma Res 2010. Epub ahead of print.
24. Arber DA, Tamaya R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol 1998;29:498-504.
25. Montone KT, van Belle P, Elenitsas R, Elder DE. Proto-oncogene c-kit in malignant melanoma: protein loss with tumor progression. Mod Pathol 1997;10:939-44.